Ignacio Mastroleo

Dr. Ignacio Mastroleo

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

2 July 2020 in Law, Innovation and Technology
Verified
Journal Article
Open access
Ignacio MastroleoIgnacio Mastroleo
Ignacio Mastroleo
FHFelicitas Holzer
Felicitas Holzer
A significant part of the literature on innovative practice in medicine relates to seizing opportunities and curbing harms for patients in desperate situations. Unfortunately, the term innovation has multiple meanings and a rich rhetorical flourish that adds confusion and misunderstanding to an already difficult debate. This paper aims to enhance the current definition of innovative practice for medicine. First, we replace the term ‘innovation’ with the more literal ‘new non-validated practice’. To identify this meaning, we analyse the traditional research ethics’ distinction between research, validated practice, and innovation in the Belmont Report. Second, we propose the following explicit definition of new non-validated practice: the first or recent use of diagnostic, therapeutic or preventive interventions that introduce a significant change, with an insufficient level of evidence of safety or efficacy for regular healthcare, and with the main aim to benefit individual patients. This definition is a promising conceptual tool to inform empirical research, ethicists, and the harmonisation of regulation and legislation (e.g. right-to-try laws).

1 December 2020 in Theoretical Medicine and Bioethics
Verified
Journal Article
Closed access
PDF file
TDTimothy Daly
Timothy Daly
Ignacio MastroleoIgnacio Mastroleo
Ignacio Mastroleo
David H. GorskiDavid H. Gorski
David H. Gorski
Stephane EpelbaumStephane Epelbaum
Stephane Epelbaum

29 January 2021 in Wellcome Open Research
Verified
Journal Article
Open access
PDF file
MSMaxwell Smith
Maxwell Smith
AAAasim Ahmad
Aasim Ahmad
TAThalia Arawi
Thalia Arawi
ADAngus Dawson
Angus Dawson
EEEzekiel J. Emanuel
Ezekiel J. Emanuel
VCVoo Teck Chuan
Voo Teck Chuan
As the world reflects upon one year since the first cases of coronavirus disease 2019 (COVID-19) and prepare for and experience surges in cases, it is important to identify the most crucial ethical issues that might lie ahead so that countries are able to plan accordingly. Some ethical issues are rather obvious to predict, such as the ethical issues surrounding the use of immunity certificates, contact tracing, and the fair allocation of vaccines globally. Yet, the most significant ethical challenge that the world must address in the next year and beyond is to ensure that we learn the ethical lessons of the first year of this pandemic. Learning from our collective experiences thus far constitutes our greatest moral obligation. Appreciating that decision-making in the context of a pandemic is constrained by unprecedented complexity and uncertainty, beginning in June 2020, an international group of 17 experts in bioethics spanning 15 countries (including low-, middle-, and high-income countries) met virtually to identify what we considered to be the most significant ethical challenges and accompanying lessons faced thus far in the COVID-19 pandemic. Once collected, the group met over the course of several virtual meetings to identify challenges and lessons that are analytically distinct in order to identify common ethical themes under which different challenges and lessons could be grouped. The result, described in this paper, is what this expert group consider to be the top five ethical lessons from the initial experience with COVID-19 that must be learned.

8 March 2022 in Journal of Alzheimer’s Disease
Verified
Journal Article
Open access
PDF file
TDTimothy Daly
Timothy Daly
Ignacio MastroleoIgnacio Mastroleo
Ignacio Mastroleo
VHVincent Henry
Vincent Henry
MBMathieu Bourdenx
Mathieu Bourdenx
Two potential disease-modifying approaches for dementia are being vigorously tested: the early targeting of the neuropathology of Alzheimer’s disease (AD) and multi-domain lifestyle interventions to promote resilience to neuropathology. We apply the “web of information” model of clinical translation to both approaches to argue firstly that tests of treatments aiming to achieve clinically meaningful outcomes should remain simple, and secondly, that building clinically-meaningful treatments should be kept separate from public health policy which means promoting wide-reaching action against risk factors now with available information.

14 July 2025 in European Journal of Risk Regulation
Verified
Journal Article
Open access
PDF file
MCMaría Inés Carabajal
María Inés Carabajal
MSMaría Florencia Santi
María Florencia Santi
CGCintia Rodríguez Garat
Cintia Rodríguez Garat
GLGian Franco Lisanti
Gian Franco Lisanti
JNJulieta Nasi
Julieta Nasi
ICInés Camilloni
Inés Camilloni
Global discussions around the risks, benefits and governance of solar radiation modification (SRM) in the climate change response portfolio are accelerating, but the topic remains nascent in Latin America and the Caribbean (LAC). In 2023, a US start-up (Make Sunsets) performed a small-scale, non-research deployment of SRM in Baja California, Mexico, without prior permission or community engagement. Their actions prompted Mexico to announce its intention to ban SRM experimentation, underscoring the need for governance to prevent irresponsible practices that could discredit legitimate research. We perform an empirical and ethical analysis of the landscape of academic discussions and media coverage on SRM in the LAC region, focusing on the Make Sunset case. Our analysis leads us to three conclusions: first, a lack of regulations in LAC that fosters mistrust, fuels perceptions of neo-colonialism and restricts potentially valuable and responsible research; second, we argue that the theatrical Make Sunsets case is not ethically justified in light of the diversity of risks associated with it; third, we offer foundational, participatory recommendations to promote effective, transparent and sustainable governance of SRM, including LAC in global conversations.